Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -6.962% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CC(C)CN(C(=O)c1ccc(=O)n(C)n1)c1nc2ccccc2s1
b. Cc1ccccc1N(C(=O)c1snc(C(N)=O)c1N)C(C)C(=O)NC1CCCCC1
Answer: a. CC(C)CN(C(=O)c1ccc(=O)n(C)n1)c1nc2ccccc2s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)CN(C(=O)c1ccc(=O)n(C)n1)c1nc2ccccc2s1
CC(C)CN(C(=O)c1ccc(=O)n(C)n1)c1nc2ccccc2s1
N-(1,3-benzothiazol-2-yl)-1-methyl-N-(2-methylpropyl)-6-oxopyridazine-3-carboxamide